NCT06053203View on ClinicalTrials.gov

Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

November 30, 2024

Conditions
Hypertensive Disorders of Pregnancy
Interventions
OTHER

Exposure of interest - Moderate or High-risk Preeclampsia

No intervention

Trial Locations (4)

Unknown

National Hospital, Abuja, Abuja

University of Abuja Teaching Hospital, Gwagwalada

Aminu Kano Teaching Hospital, Kano

Murtala Muhammad Specialist Hospital, Kano

All Listed Sponsors
collaborator

University of Abuja Teaching Hospital

OTHER

collaborator

Aminu Kano Teaching Hospital

OTHER

collaborator

Murtala Muhammad Specialist Hospital

OTHER

collaborator

National Hospital, Abuja

OTHER_GOV

lead

Washington University School of Medicine

OTHER

NCT06053203 - Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study | Biotech Hunter | Biotech Hunter